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Acetaldehyde (l-20 mM) was metabolized at high rates and in a dose-dependent manner in isolated human 
and baboon kidney-cortex tubules. Acetaldehyde removal was accompanied by a large accumulation of 
acetate in both human and baboon tubules. By contrast, a large synthesis of ethanol was observed only 
in baboon tubules. Consistent with the latter finding, ethanol was found to be metabolized at significant 
rates in baboon but not human tubules. In the tubules from both species, a significant fraction of the acetal- 
dehyde removed was also completely oxidized to CO, and H,O. These results suggest hat, in both man 
and baboon, the kidneys participate in the in vivo metabolism of acetaldehyde; they also suggest hat, in 
contrast with the human kidneys, the baboon kidneys contribute to the detoxication of circulating ethanol. 
Acetaldehyde; Ethanol; Acetaldehyde metabolism; (Human, Baboon kidney) 
1. INTRODUCTION 
Acetaldehyde, the first oxidation product of 
ethanol metabolism in the liver, is a very reactive 
compound to which many of the toxic effects of 
ethanol consumption are attributed [ 11. Although 
most of the acetaldehyde formed by liver alcohol 
dehydrogenase (EC 1.1 .l .l) under in vivo condi- 
tions is considered to be oxidized instantaneously 
to acetate by aldehyde dehydrogenase (EC 
1.2.1.3), some acetaldehyde scapes from the liver 
intact and is found in the circulating blood after 
ethanol administration in man [2,3] and ex- 
perimental animals [4-61. Apart from the liver, 
other organs may contribute significantly to the 
degradation of circulating acetaldehyde as sug- 
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gested by the high acetaldehyde concentration 
found in hepatic venous blood as compared with 
that in arterial blood 13-61 but their capacity to 
degrade acetaldehyde has not been well defined. 
The above considerations, together with the 
observation that the human kidney contains some 
acetaldehyde dehydrogenase activity [7,8], led to 
the experiments reported here in which the capaci- 
ty of isolated human and baboon kidney-cortex 
tubules to metabolize acetaldehyde was 
determined. 
2. MATERIALS AND METHODS 
Fresh normal kidney cortex was obtained from 
the uninvolved pole of kidneys removed for 
neoplasm from 18 h fasted patients as well as from 
normal kidneys removed from 18 h fasted baboons 
(Papio papio) used in heart transplantation ex- 
periments. Specimens of cortex were immediately 
dissected and placed in ice-cold Krebs-Henseleit 
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buffer gassed with a mixture of OZ/COZ (19 : 1) un- 
til the beginning of the tubule-isolation period 
(usually within 10 min). Kidney tubules were 
prepared by collagenase treatment as in [9, lo]. In- 
cubations were performed at 37°C in a shaking 
water bath in 25 ml hermetically stoppered 
Erlenmeyer flasks in an atmosphere of 02/CO2 
(19 : 1). The tubule obtained were incubated for 30 
or 60 min with various concentrations of 
acetaldehyde or with 5 mM ethanol in 4 ml Krebs- 
Henseleit medium. In all experiments, each ex- 
perimental condition was carried out in duplicate. 
Incubations were terminated by adding HC104 
(2%, v/v, final concentration) to each flask. In 
each experiment, zero-times flasks were prepared 
with acetaldehyde or ethanol by adding HC104 
before the tubules. At the end of each experiment, 
the flasks were cooled to 4°C for 30 min to avoid 
evaporation of acetaldehyde on removal of the 
stoppers; after removal of the denatured protein 
by centrifugation (4000 x g for 10 min at O’C), the 
supernatant was neutralized with 20% (w/v) KOH 
and kept on ice before metabolites were assayed. 
In experiments where [U-r4C]acetaldehyde ‘was 
used as substrate, incubation, deproteinization, 
collection and measurement of the 14C02 formed 
were carried out as in [ll]; the medium was then 
treated as described above. 
Acetaldehyde was determined by the method of 
Bernt and Bergmeyer [ 121, and ethanol according 
to Bernt and Gutmann [ 131. Acetate was measured 
by the Boehringer acetate assay kit (Meylan, 
France). The dry weight of the amount of tubules 
added to the flasks was determined as in [9]. Net 
substrate utilization and product formation were 
calculated as the difference between the total con- 
tents of the flasks (tissue + medium) at the start 
(zero-time flasks) and after the period of incuba- 
tion. The metabolic rates are expressed in pmol 
substance removed (or produced)/g dry wt tubule 
fragments per unit time. They are reported as 
means +- SE. The rates of conversion of 
[U-‘4C]acetaldehyde into 14C02 were calculated by 
dividing the radioactivity in 14C02 by the specific 
activity of the labelled acetaldehyde determined in 
the zero-time samples for each experiment. 
Acetaldehyde, which was freshly redistilled prior 
to use, was supplied by Merck (Darmstadt) and ab- 
solute ethanol was obtained from Prolabo (Paris). 
[U-‘4C]Acetaldehyde (7.4 mCi/mmol) was sup- 
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plied by New England Nuclear (Boston, MA). En- 
zymes and coenzymes were supplied by Boehringer 
(Meylan). 
3. RESULTS AND DISCUSSION 
3.1. Characteristics of acetaldehyde metabolism in 
human and baboon kidney tubules 
As shown in tables 1 and 2, both human and ba- 
boon tubules readily metabolized acetaldehyde at 
all concentrations of acetaldehyde tested. Acetal- 
dehyde utilization, which was approximately linear 
over a 60 min incubation period, increased with the 
substrate concentration and reached its maximum 
at 10 mM acetaldehyde. This observation that in- 
tact renal tubules metabolized high concentrations 
of acetaldehyde at high rates and in a dose- 
dependent manner with increasing substrate con- 
centrations is in contrast with the results of Ceder- 
baum and Rubin [14] who found that, in rat 
kidney mitochondria, acetaldehyde oxidation was 
saturated at a substrate concentration of 0.08 mM. 
This also suggests that one (or several) of the isoen- 
zymes of aldehyde dehydrogenase, which initiate 
acetaldehyde metabolism and are found in renal 
cortex [7,8,15], has a much higher K, for 
acetaldehyde than that found in rat kidney mito- 
chondria. 
In both human and baboon kidney tubules, a 
large fraction of the acetaldehyde removed was 
recovered as acetate, whose accumulation was also 
approximately linear with time (tables 1,2). This 
means that, thanks to aldehyde dehydrogenase, 
acetate was formed at a faster rate than it was 
capable of being metabolized by acetyl-CoA syn- 
thetase (EC 6.2.1.1), an enzyme also known to be 
present in renal tissue [16,17]; thus acetyl-CoA 
synthetase appears to be rate-limiting in renal 
acetaldehyde metabolism in the two species tudied 
here. 
In human kidney tubules, ethanol synthesis was 
also linear with time and dose-dependent but it oc- 
curred at very low rates and never represented 
more than 5.3% of the acetaldehyde utilization 
(table 1). In contrast, high rates of ethanol syn- 
thesis were observed in baboon tubules at all the 
acetaldehyde concentrations used (table 2). This 
suggests that the alcohol dehydrogenase found in 
human kidney [l&19] is not very active when com- 
pared with that in baboon kidney. This view is fur- 
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TABLE 1 
Metabolism of various concentrations of acetaldehyde in human kidney-cortex 
tubules 
Parameter Incubation Acetaldehyde concentration 
measured (min) 
1 mM 2mM 5mM 10 mM 20 mM 
Acetaldehyde 30 
removal 
60 
Ethanol 
synthesis 
30 
60 
Acetate 30 
accumulation 
60 
- 277.0 - 335.2 - 372.3 -518.4 -489.3 
+ 30.2 f 25.8 f 73.1 * 49.7 rt 82.2 
- 568.3 - 669.1 - 728.0 - 885.3 - 835.5 
+ 27.6 * 30.0 + 29.2 ?I 37.0 + 21.4 
+ 2.8 + 10.8 + 17.6 + 22.4 + 21.0 
* 0.3 * 3.7 + 4.4 + 4.1 f 2.0 
+ 5.7 + 20.9 + 37.1 + 46.5 + 36.8 
+ 2.7 5 2.6 f 7.6 + 0.3 f 6.5 
+ 225.2 + 226.9 + 244.8 + 227.3 + 214.7 
f 34.5 + 32.6 f 29.1 f 29.6 f 43.8 
+ 385.3 +413.4 +424.8 + 419.9 + 337.6 
f 36.4 f 33.5 + 23.2 * 20.7 + 27.1 
Kidney tubules were incubated as described in section 2. Each flask contained 4.9 
+ 1 .O mg dry wt tubules. Results (in pmol/g dry wt) for metabolite removal (-) 
or production (+) are reported as means + SE for 4 experiments performed in 
duplicate 
TABLE 2 
Metabolism of various concentrations of acetaldehyde in baboon kidney-cortex 
tubules 
Parameter Incubation Acetaldehyde concentration 
measured (min) 
1 mM 2mM 5mM 10 mM 20 mM 
Acetaldehyde 30 -481.7 - 644.1 - 751.1 -1177.0 - 944.9 
removal f 59.5 + 88.4 f 187.3 f 134.7 + 55.7 
60 - 929.3 - 1168.7 - 1534.0 - 1723.0 - 1480.6 
f 123.4 + 156.1 f 219.5 +- 292.5 + 238.2 
Ethanol 30 + 83.4 + 155.2 + 262.7 + 231.5 + 199.8 
synthesis & 13.0 f 25.9 f 40.1 f 47.5 ?I 42.6 
60 +142.1 + 255.9 + 501.7 + 441.3 + 303.5 
f 17.1 + 32.3 f 68.3 I& 86.5 + 46.0 
Acetate 30 +259.1 + 295.4 + 394.4 + 412.4 + 381.9 
accumulation f 44.5 + 31.6 f 51.1 + 64.1 f 61.5 
60 +475.9 + 571.4 + 751.3 + 790.1’ + 598.2 
f 114.3 f 64.9 f 102.6 f 119.9 k 62.3 
Kidney tubules were incubated as described in section 2. Each flask contained 2.8 
f 0.2 mg dry wt tubules. Results (in pmol/g dry wt) for metabolite removal (- ) 
or production (+) are reported as means + SE for 4 experiments performed in 
duplicate 
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ther supported by our observation that, with 5 mM 
ethanol as substrate, appreciable amounts of 
ethanol were removed by baboon tubules (180 + 
29.7 Fmol/g dry wt per h; n = 4), whereas negligi- 
ble amounts were removed by human tubules 
(lO.lk5.8 gmol/g dry wt per h; n=4). 
Tables 1 and 2 also show that, in both human 
and baboon kidney tubules, significant amounts of 
the acetaldehyde removed were not accounted for 
by the sum of the acetate accumulated plus the 
ethanol synthesized, suggesting that some acetal- 
dehyde was further oxidized beyond the stage of 
acetate. Complete oxidation of acetaldehyde was 
demonstrated by measuring the conversion of 5 
mM [U-‘4C]acetaldehyde into 14C02 in baboon 
kidney tubules; in these experiments (n = 4), 
acetaldehyde removal was 1084.9 + 13.6 pmol/g 
dry wt per h and its conversion into 14COz was 
191.2 + 5.1 pmol/g dry wt per h, representing 
17.6% of the acetaldehyde removed, a value close 
to that calculated from the data in table 2. Thus, 
a significant fraction of the acetaldehyde removed 
was completely oxidized to CO2 and Hz0 in ba- 
boon and presumably also in human tubules. 
3.2. Physiological relevance 
This study is the first to demonstrate the large 
capacity of the human and baboon renal cortex to 
metabolize acetaldehyde. Although the concentra- 
tion of acetaldehyde in arterial blood of humans 
and baboons after ethanol consumption is much 
lower (l-20 PM) than the acetaldehyde concentra- 
tions used in the present work, our data strongly 
suggest hat the kidneys of these two species can 
significantly participate in the extrahepatic elimin- 
ation of acetaldehyde in vivo. In this respect, it 
should be noted that, after ethanol administration, 
the rat kidney has been shown to extract 50% of 
the acetaldehyde present in the renal artery [4]. It 
should also be stressed that all the isoenzymes of 
aldehyde dehydrogenase present in renal cortex are 
not sensitive to the inhibitory effect of disulfiram 
[7], a compound used to deter alcoholics from 
drinking ethanol; since the administration of 
disulfiram leads to an increase in blood acetal- 
dehyde to concentrations of up to 2.3 mM 121, it is 
conceivable that our observations are of ‘physiolo- 
gical’ value and that, in disulfiram-treated pa- 
tients, the kidneys contribute to maintain the 
blood acetaldehyde concentration at relatively safe 
116 
levels by converting this very toxic compound into 
acetate, CO2 and H20. 
This work also shows that the baboon renal cor- 
tex is unique when compared with a rat, dog, 
guinea-pig [20] and human renal cortex in that it is 
able to synthesize and metabolize ethanol at 
significant rates. Therefore, our data suggest hat 
the baboon kidneys contribute to the combustion 
of ethanol to a much greater extent than previously 
believed in other species where ethanol is con- 
sidered to be almost exclusively metabolized by the 
liver [21,22]. In addition, our results indicate that 
this species difference should be considered when 
using the baboon as an experimental model for 
alcohol metabolism in humans. 
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